Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Carrillo

Showing results (451-460 of 524) with videos related to

Pageof 53
Sort By:
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|October 21, 2021
Working Group Recommendations for the Practice of Teleneuropsychology in Latin AmericaLucía Crivelli, Yakeel T Quiroz, Ismael L Calandri, et al.
Neurology|July 31, 2013
Imaging markers for Alzheimer disease: which vs howGiovanni B Frisoni, Martina Bocchetta, Gael Chételat, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 23, 2025
Tau biology, biomarkers, and therapeuticsBess Frost, Hartmuth Kolb, Alicia Algeciras-Schimnich, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 15, 2026
Provider and patient perspectives on the diagnosis and treatment of Alzheimer's disease: A global perspective from the Global Alzheimer's Leadership Series (GoALS)Philippe Amouyel, Sandrine Andrieu, Angela Bradshaw, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 3, 2014
Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's diseaseDerek L G Hill, Adam J Schwarz, Maria Isaac, et al.
Biomarkers in Medicine|August 25, 2012
Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42Niklas Mattsson, Ingrid Zegers, Ulf Andreasson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 15, 2018
The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research RoundtableDavid S Knopman, Samantha Budd Haeberlein, Maria C Carrillo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthMark A Espeland, Heather M Snyder, Laura D Baker, et al.
The Lancet. Neurology|October 25, 2020
Amyloid-PET and <sup>18</sup>F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementiasGaël Chételat, Javier Arbizu, Henryk Barthel, et al.
Neurobiology of Aging|April 12, 2021
EEG measures for clinical research in major vascular cognitive impairment: recommendations by an expert panelClaudio Babiloni, Xianghong Arakaki, Laura Bonanni, et al.
Pageof 53

Showing results (451-460 of 524) with videos related to

Sort By:
Pageof 53
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|October 21, 2021
Working Group Recommendations for the Practice of Teleneuropsychology in Latin AmericaLucía Crivelli, Yakeel T Quiroz, Ismael L Calandri, et al.
Neurology|July 31, 2013
Imaging markers for Alzheimer disease: which vs howGiovanni B Frisoni, Martina Bocchetta, Gael Chételat, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 23, 2025
Tau biology, biomarkers, and therapeuticsBess Frost, Hartmuth Kolb, Alicia Algeciras-Schimnich, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 15, 2026
Provider and patient perspectives on the diagnosis and treatment of Alzheimer's disease: A global perspective from the Global Alzheimer's Leadership Series (GoALS)Philippe Amouyel, Sandrine Andrieu, Angela Bradshaw, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 3, 2014
Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's diseaseDerek L G Hill, Adam J Schwarz, Maria Isaac, et al.
Biomarkers in Medicine|August 25, 2012
Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42Niklas Mattsson, Ingrid Zegers, Ulf Andreasson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 15, 2018
The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research RoundtableDavid S Knopman, Samantha Budd Haeberlein, Maria C Carrillo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthMark A Espeland, Heather M Snyder, Laura D Baker, et al.
The Lancet. Neurology|October 25, 2020
Amyloid-PET and <sup>18</sup>F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementiasGaël Chételat, Javier Arbizu, Henryk Barthel, et al.
Neurobiology of Aging|April 12, 2021
EEG measures for clinical research in major vascular cognitive impairment: recommendations by an expert panelClaudio Babiloni, Xianghong Arakaki, Laura Bonanni, et al.
Pageof 53